CA1306699C - Fervescence composition containing 15-keto-pges - Google Patents

Fervescence composition containing 15-keto-pges

Info

Publication number
CA1306699C
CA1306699C CA000566799A CA566799A CA1306699C CA 1306699 C CA1306699 C CA 1306699C CA 000566799 A CA000566799 A CA 000566799A CA 566799 A CA566799 A CA 566799A CA 1306699 C CA1306699 C CA 1306699C
Authority
CA
Canada
Prior art keywords
keto
pges
dihydro
group
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000566799A
Other languages
English (en)
French (fr)
Inventor
Ryuzo Ueno
Ryuji Ueno
Tomio Oda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Application granted granted Critical
Publication of CA1306699C publication Critical patent/CA1306699C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA000566799A 1987-05-15 1988-05-13 Fervescence composition containing 15-keto-pges Expired - Lifetime CA1306699C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP11936787 1987-05-15
JP119367/1987 1987-05-15
JP235962/1987 1987-09-17
JP23596287 1987-09-17

Publications (1)

Publication Number Publication Date
CA1306699C true CA1306699C (en) 1992-08-25

Family

ID=26457126

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000566799A Expired - Lifetime CA1306699C (en) 1987-05-15 1988-05-13 Fervescence composition containing 15-keto-pges

Country Status (10)

Country Link
US (1) US5001154A (enExample)
EP (1) EP0292177B1 (enExample)
KR (1) KR920007570B1 (enExample)
AU (1) AU603005B2 (enExample)
CA (1) CA1306699C (enExample)
DE (1) DE3869471D1 (enExample)
ES (1) ES2038289T3 (enExample)
GB (1) GB2225531A (enExample)
GR (1) GR3004146T3 (enExample)
ZA (1) ZA886910B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
EP0310305B1 (en) * 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Cathartics
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
CA2022372C (en) * 1989-08-09 2000-05-02 Ryuji Ueno Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
TW224942B (enExample) * 1990-04-04 1994-06-11 Adka Ueno Kk
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK0503887T3 (da) * 1991-03-14 1996-09-16 R Tech Ueno Ltd Fremme af sårheling med 15-ketoprostaglandinforbindelser
US20040161563A1 (en) * 2003-02-19 2004-08-19 Wellman Raymond L. Slip collar for joining fume duct sections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2422924A1 (de) * 1974-05-11 1975-11-27 Merck Patent Gmbh Thiaprostaglandine
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins

Also Published As

Publication number Publication date
EP0292177B1 (en) 1992-03-25
ES2038289T3 (es) 1993-07-16
KR920007570B1 (ko) 1992-09-07
DE3869471D1 (de) 1992-04-30
GB8821816D0 (en) 1988-10-19
AU603005B2 (en) 1990-11-01
GB2225531A (en) 1990-06-06
ZA886910B (en) 1989-05-30
EP0292177A1 (en) 1988-11-23
KR880013561A (ko) 1988-12-21
GR3004146T3 (enExample) 1993-03-31
AU2221288A (en) 1990-03-22
US5001154A (en) 1991-03-19

Similar Documents

Publication Publication Date Title
CA1306699C (en) Fervescence composition containing 15-keto-pges
US5194429A (en) Ocular hypotensive agents
JPH0571567B2 (enExample)
EP1392318B1 (en) 15-keto-prostaglandins for treating drug-induced constipation
EP0345951B1 (en) Tracheobronchodilator
EP0580268B1 (en) Ocular hypotensive agents
AU2002251554A1 (en) Composition for Treating Drug-Induced Constipation
EP0343904B1 (en) Hypersphyxia causing composition
ES2310013T3 (es) Uso de compuestos de 15-ceto-prostaglandina e como antagonistas de endotelina.
CA2030344C (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
JP2003527430A (ja) １５−ケトプロスタグランジンまたはその誘導体を含むアポトーシス抑制剤
US5236907A (en) Ocular hypotensive agents
US5221690A (en) Increasing the choroidal blood flow
JPH0987179A (ja) 視神経障害改善剤
DE69123892T2 (de) Behandlung von Katarakt mit prostacyclinverbindungen
NZ226198A (en) Fervescence (temperature raising) composition comprising 15-keto-pge
US5362751A (en) Tracheobronchodilator using 16-substituted PGEs
US5169863A (en) Hypersphyxia-causing methods
JP2760514B2 (ja) 循環機能昂進剤
CA2022323C (en) Excretion of potassium ion by prostanoic acid derivatives
JPH01151519A (ja) 体温上昇剤
CA2022372C (en) Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
JPH0296528A (ja) 眼圧降下剤
JP2633495B2 (ja) 循環機能昂進剤
US5234954A (en) Treatment of hyperlipidemia with 15-keto-prostaglandin compounds

Legal Events

Date Code Title Description
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121205